Sanofi (SNY) Long-Term Debt Repayments (2016 - 2025)
Historic Long-Term Debt Repayments for Sanofi (SNY) over the last 17 years, with Q4 2025 value amounting to -$3.1 billion.
- Sanofi's Long-Term Debt Repayments fell 32570.19% to -$3.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was -$5.5 billion, marking a year-over-year decrease of 1456.93%. This contributed to the annual value of -$3.0 billion for FY2025, which is 30800.45% down from last year.
- Latest data reveals that Sanofi reported Long-Term Debt Repayments of -$3.1 billion as of Q4 2025, which was down 32570.19% from -$498.0 million recorded in Q3 2025.
- Over the past 5 years, Sanofi's Long-Term Debt Repayments peaked at $3.6 billion during Q4 2022, and registered a low of -$5.0 billion during Q2 2021.
- Over the past 5 years, Sanofi's median Long-Term Debt Repayments value was -$1.1 billion (recorded in 2024), while the average stood at -$1.2 billion.
- Within the past 5 years, the most significant YoY rise in Sanofi's Long-Term Debt Repayments was 52558.13% (2025), while the steepest drop was 32570.19% (2025).
- Over the past 5 years, Sanofi's Long-Term Debt Repayments (Quarter) stood at -$1.4 billion in 2021, then skyrocketed by 365.09% to $3.6 billion in 2022, then plummeted by 209.53% to -$4.0 billion in 2023, then soared by 81.91% to -$717.0 million in 2024, then plummeted by 325.7% to -$3.1 billion in 2025.
- Its Long-Term Debt Repayments stands at -$3.1 billion for Q4 2025, versus -$498.0 million for Q3 2025 and $693.9 million for Q2 2025.